We are live on ! Find out more
PG

Prostatis Group Portfolio holdings

AUM $391M
1-Year Est. Return 20.37%
This Fund
S&P 500
This Quarter Est. Return
-4.6%
1 Year Est. Return
+20.37%
3 Year Est. Return
+56.13%
5 Year Est. Return
+74.88%
10 Year Est. Return
AUM
$86.8M
AUM Growth
+$22.6M
Cap. Flow
+$29.2M
Cap. Flow %
33.63%
Top 10 Hldgs %
53.75%
Holding
75
New
28
Increased
19
Reduced
14
Closed
11
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIVO icon
1
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.33B
$9.52M 10.97%
297,262
+49,430
+20% +$1.71M
PALC icon
2
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
$211M
$6.6M 7.61%
+206,903
New +$7.39M
SPGP icon
3
Invesco S&P 500 GARP ETF
SPGP
$2.19B
$5.78M 6.67%
+77,306
New +$6.43M
BIV icon
4
Vanguard Intermediate-Term Bond ETF
BIV
$29.1B
$5.47M 6.3%
+74,381
New +$5.75M
XMMO icon
5
Invesco S&P MidCap Momentum ETF
XMMO
$7.23B
$4.01M 4.62%
+57,437
New +$4.4M
BSV icon
6
Vanguard Short-Term Bond ETF
BSV
$44.7B
$3.72M 4.29%
49,732
-1,839
-4% -$141K
BUFD icon
7
FT Vest Fund of Deep Buffer ETFs
BUFD
$1.92B
$3.52M 4.06%
+184,380
New +$3.66M
SDVY icon
8
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.4B
$2.79M 3.22%
+120,832
New +$3.07M
FTCS icon
9
First Trust Capital Strength ETF
FTCS
$7.88B
$2.78M 3.21%
+41,913
New +$3.01M
RSP icon
10
Invesco S&P 500 Equal Weight ETF
RSP
$96.4B
$2.45M 2.82%
+19,226
New +$2.71M
MSFT icon
11
Microsoft
MSFT
$2.93T
$2.31M 2.66%
9,905
+4,560
+85% +$1.2M
AAPL icon
12
Apple
AAPL
$4.9T
$2.16M 2.48%
15,595
+6,738
+76% +$1.06M
TMO icon
13
Thermo Fisher Scientific
TMO
$198B
$2.08M 2.4%
4,104
+1,193
+41% +$668K
TIP icon
14
iShares TIPS Bond ETF
TIP
$14.5B
$2.03M 2.34%
+19,329
New +$2.19M
FTSM icon
15
First Trust Enhanced Short Maturity ETF
FTSM
$6.5B
$1.99M 2.29%
33,478
-433,163
-93% -$25.7M
BLV icon
16
Vanguard Long-Term Bond ETF
BLV
$5.85B
$1.94M 2.23%
+26,916
New +$2.13M
BNDX icon
17
Vanguard Total International Bond ETF
BNDX
$82.2B
$1.64M 1.89%
+34,342
New +$1.71M
HYG icon
18
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$1.57M 1.81%
+22,034
New +$1.67M
AMZN icon
19
Amazon
AMZN
$2.66T
$1.55M 1.79%
13,726
+8,189
+148% +$1.04M
HYLS icon
20
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
$1.48M 1.7%
+38,512
New +$1.57M
AMGN icon
21
Amgen
AMGN
$198B
$1.31M 1.51%
5,800
+4,596
+382% +$1.11M
TSLA icon
22
Tesla
TSLA
$1.43T
$1.24M 1.42%
+4,660
New +$1.3M
GLD icon
23
SPDR Gold Trust
GLD
$130B
$1.05M 1.21%
+6,783
New +$1.09M
BRK.B icon
24
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.01M 1.16%
+3,764
New +$1.07M
IVV icon
25
iShares Core S&P 500 ETF
IVV
$881B
$1M 1.16%
+2,801
New +$1.12M

Similar funds

Prostatis Group's Q3 2022 Portfolio in Review

As of Q3 2022, Prostatis Group held 75 positions worth $86.8M, up 35% from $64.2M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Prostatis Group deployed $29.2M of net new capital in Q3 2022, opening 28 new positions and adding to 19 existing holdings. Its largest new stake was Pacer Lunt Large Cap Multi-Factor Alternator ETF: 206,903 shares worth $6.6M.

By sector, the portfolio is most concentrated in Healthcare at 6% of assets, up from 4.6% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was First Trust Enhanced Short Maturity ETF, an estimated $25.7M trimmed.

  • Prostatis Group's largest Q3 2022 buy was Pacer Lunt Large Cap Multi-Factor Alternator ETF: 206,903 shares worth $6.6M.
  • Prostatis Group added most to Amplify CWP Enhanced Dividend Income ETF in Q3 2022, an estimated $1.71M increase.
  • Prostatis Group's biggest Q3 2022 reduction was First Trust Enhanced Short Maturity ETF, cutting an estimated $25.7M.
  • Prostatis Group fully exited iShares Core High Dividend ETF in Q3 2022, selling an estimated $5.62M.
  • Prostatis Group's ten largest holdings make up 54% of its $86.8M portfolio in Q3 2022.
  • Prostatis Group opened 28 new positions and closed 11 in Q3 2022.
  • Prostatis Group's portfolio value rose 35% quarter-over-quarter to $86.8M.

Based on Prostatis Group's 13F filing for Q3 2022, filed 23 Mar 2023.